FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972752014> ?p ?o ?g. }

• W1972752014 endingPage "S240" @default.
• W1972752014 startingPage "S240" @default.
• W1972752014 abstract "48 consecutive patients (pts) with muscle-invasive bladder cancer were treated between November 1988 and May 1993. All pts had pure transitional carcinoma, absence of diffuse Tis, and clinic N0M0 stage. 39 pts had T2-3a stages and 9 had T3b-4a. The treatment consisted of RTU, neoadjuvant chemotherapy M-VAC (CT) (2–4 cycles), and radiotherapy (RT) (44 Gy). RT was continued to 64 Gy in pts with biopsy-proven absence of invasive cancer (CR). Cystectomy was performed in pts with residual invasive tumor. 9 pts did not receive RT: 6 with failure to CT underwent immediate cystectomy, and 3 with CR received only CT. The CR rate to neoadjuvant treatment was 75%. After a mean follow-up of 35 months, 24 pts (50%) had preserved bladders free of invasive tumor and functioning well. The actuarial survival and disease free survival at 3 years were, respectively, 49% and 56%. Of the 24 currently surviving pts 87% have their bladder preserved. 5 pts required salvage cystectomy for recurrent invasive cancer or diffuse Tis. 9 pts had recurrent superficial bladder tumors, and 5 of them preserved their bladders after further RTU and BCG. The response to CT had prognostic value for survival (P = .0004). Long-term bladder sparing was significantly associated with absence of hydronephrosis and bladder-confined disease (T2-T3a). Severe complications were: 1 death for fulminant hepatitis after CT, 2 late radiation cystitis that required cystectomy, with one death in postoperatory, and colovesical fistula that needed rectosygmoidectomy. The long-term bladder preservation is feasible in a selected group of pts by multimodality treatment. Most surviving pts had their bladders intact. 48 consecutive patients (pts) with muscle-invasive bladder cancer were treated between November 1988 and May 1993. All pts had pure transitional carcinoma, absence of diffuse Tis, and clinic N0M0 stage. 39 pts had T2-3a stages and 9 had T3b-4a. The treatment consisted of RTU, neoadjuvant chemotherapy M-VAC (CT) (2–4 cycles), and radiotherapy (RT) (44 Gy). RT was continued to 64 Gy in pts with biopsy-proven absence of invasive cancer (CR). Cystectomy was performed in pts with residual invasive tumor. 9 pts did not receive RT: 6 with failure to CT underwent immediate cystectomy, and 3 with CR received only CT. The CR rate to neoadjuvant treatment was 75%. After a mean follow-up of 35 months, 24 pts (50%) had preserved bladders free of invasive tumor and functioning well. The actuarial survival and disease free survival at 3 years were, respectively, 49% and 56%. Of the 24 currently surviving pts 87% have their bladder preserved. 5 pts required salvage cystectomy for recurrent invasive cancer or diffuse Tis. 9 pts had recurrent superficial bladder tumors, and 5 of them preserved their bladders after further RTU and BCG. The response to CT had prognostic value for survival (P = .0004). Long-term bladder sparing was significantly associated with absence of hydronephrosis and bladder-confined disease (T2-T3a). Severe complications were: 1 death for fulminant hepatitis after CT, 2 late radiation cystitis that required cystectomy, with one death in postoperatory, and colovesical fistula that needed rectosygmoidectomy. The long-term bladder preservation is feasible in a selected group of pts by multimodality treatment. Most surviving pts had their bladders intact." @default.
• W1972752014 created "2016-06-24" @default.
• W1972752014 creator A5003547580 @default.
• W1972752014 creator A5006362605 @default.
• W1972752014 creator A5006532865 @default.
• W1972752014 creator A5008091556 @default.
• W1972752014 creator A5015603311 @default.
• W1972752014 creator A5066213441 @default.
• W1972752014 creator A5068141709 @default.
• W1972752014 creator A5069061409 @default.
• W1972752014 date "1995-11-01" @default.
• W1972752014 modified "2023-10-18" @default.
• W1972752014 title "1149 Bladder sparing by chemotherapy and radiation in patients with invasive bladder cancer" @default.
• W1972752014 doi "https://doi.org/10.1016/0959-8049(95)96395-t" @default.
• W1972752014 hasPublicationYear "1995" @default.
• W1972752014 type Work @default.
• W1972752014 sameAs 1972752014 @default.
• W1972752014 citedByCount "0" @default.
• W1972752014 crossrefType "journal-article" @default.
• W1972752014 hasAuthorship W1972752014A5003547580 @default.
• W1972752014 hasAuthorship W1972752014A5006362605 @default.
• W1972752014 hasAuthorship W1972752014A5006532865 @default.
• W1972752014 hasAuthorship W1972752014A5008091556 @default.
• W1972752014 hasAuthorship W1972752014A5015603311 @default.
• W1972752014 hasAuthorship W1972752014A5066213441 @default.
• W1972752014 hasAuthorship W1972752014A5068141709 @default.
• W1972752014 hasAuthorship W1972752014A5069061409 @default.
• W1972752014 hasConcept C121608353 @default.
• W1972752014 hasConcept C126322002 @default.
• W1972752014 hasConcept C126894567 @default.
• W1972752014 hasConcept C141071460 @default.
• W1972752014 hasConcept C146357865 @default.
• W1972752014 hasConcept C151730666 @default.
• W1972752014 hasConcept C2775910329 @default.
• W1972752014 hasConcept C2776694085 @default.
• W1972752014 hasConcept C2778769751 @default.
• W1972752014 hasConcept C2780352672 @default.
• W1972752014 hasConcept C509974204 @default.
• W1972752014 hasConcept C71924100 @default.
• W1972752014 hasConcept C77411442 @default.
• W1972752014 hasConcept C86803240 @default.
• W1972752014 hasConceptScore W1972752014C121608353 @default.
• W1972752014 hasConceptScore W1972752014C126322002 @default.
• W1972752014 hasConceptScore W1972752014C126894567 @default.
• W1972752014 hasConceptScore W1972752014C141071460 @default.
• W1972752014 hasConceptScore W1972752014C146357865 @default.
• W1972752014 hasConceptScore W1972752014C151730666 @default.
• W1972752014 hasConceptScore W1972752014C2775910329 @default.
• W1972752014 hasConceptScore W1972752014C2776694085 @default.
• W1972752014 hasConceptScore W1972752014C2778769751 @default.
• W1972752014 hasConceptScore W1972752014C2780352672 @default.
• W1972752014 hasConceptScore W1972752014C509974204 @default.
• W1972752014 hasConceptScore W1972752014C71924100 @default.
• W1972752014 hasConceptScore W1972752014C77411442 @default.
• W1972752014 hasConceptScore W1972752014C86803240 @default.
• W1972752014 hasLocation W19727520141 @default.
• W1972752014 hasOpenAccess W1972752014 @default.
• W1972752014 hasPrimaryLocation W19727520141 @default.
• W1972752014 hasRelatedWork W1036257620 @default.
• W1972752014 hasRelatedWork W2063318372 @default.
• W1972752014 hasRelatedWork W2076399298 @default.
• W1972752014 hasRelatedWork W2411104439 @default.
• W1972752014 hasRelatedWork W2937517875 @default.
• W1972752014 hasRelatedWork W40279807 @default.
• W1972752014 hasRelatedWork W4213013831 @default.
• W1972752014 hasRelatedWork W4316019291 @default.
• W1972752014 hasRelatedWork W4324136739 @default.
• W1972752014 hasRelatedWork W2534617614 @default.
• W1972752014 hasVolume "31" @default.
• W1972752014 isParatext "false" @default.
• W1972752014 isRetracted "false" @default.
• W1972752014 magId "1972752014" @default.
• W1972752014 workType "article" @default.